Feature Story
Why Design Thinking is Crucial for Medical Device Innovation
Interview with Madorra CEO Holly Rockweiler
read more
More Client & Industry News
Alio Holds Inaugural Patient & Family Advisory Council Meeting
Jun. 23, 2022 -- After formally announcing the formation of our Patient & Family Advisory Council (PFAC) last month, we convened the group to hold our first meeting on June 16, 2022. The Alio PFAC is an advisory group designed to ensure we keep the patient at the center of everything we do – from understanding unique pain points in disease management to wearability of our SmartPatch – we want to ensure our targeted solution is built with the end-user in mind. read more
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
May 13, 2022 -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company, and its majority-owned subsidiary Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”), a commercial-stage cancer prevention medical diagnostics company, today announced that PAVmed and Lucid Chairman & Chief Executive Officer Lishan Aklog, M.D. was selected as one of the Top 50 Healthcare Technology CEOs of 2022 by The Healthcare Technology Report. read more
Neurava wins Innovation of the Year Mira Award
Apr. 23, 2022 -- Co-founders and Purdue University grad students Jay Shah and Vivek Ganesh developed a wearable device for refractory epilepsy patients who are at high risk for a deadly complication of the disease that affects one-third of people with epilepsy. The device monitors key biomarkers and sends a wireless signal to a caregiver when it detects abnormalities typically linked to the complication. read more
Alio Receives First FDA 510(k) Clearance
Apr. 13, 2022 -- Today, Alio Inc., announced it received FDA 510(k) clearance for its remote monitoring system intended for use by healthcare professionals to intermittently collect physiological data in home use settings. Collected physiological data includes skin temperature, auscultation sound data and heart rate. read more
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
Mar. 17, 2022 -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced that physicians at the Clinica Porto Azul in Barranquilla, Colombia successfully implanted the Company’s PortIO™ Intraosseous Infusion System in three patients—the first human implants of the device—as part of its IRB-approved first-in-human (FIH) clinical study of up to 40 patients. read more

Feb. 4, 2022
Nephrodite Named One of 22 Startups to Watch in 2022 - Recognized for Holly, an implantable hemofilter that connects to a wearable pouch

Jan 28, 2022
Partnerships For Emerging Healthcare Startups: How To Find The Right Fit - Authored by CEO and Co-Founder of Alio, Dave Kuraguntla

Dec. 1, 2021
Alio Announces Partnership with Lifeline for Dialysis Access Patient Monitoring - Leveraging artificial intelligence and its SmartPatch sensor technology

Nov. 8, 2021
Nano Entrepreneurship Network podcast - Using Nanotechnology to Treat Glaucoma: A Conversation with Rui Jing Jiang, Co-Founder, CEO, and Director of Avisi Technologies

Sept. 8, 2021
FDA Grants Madorra Breakthrough Device Designation Status for Treatment of Moderate to Severe Vulvovaginal Atrophy

May 18-20, 2021
Alio Receives 1st Prize from the Jon DeHaan Foundation for Innovation in Wearable Device for Continuous, Non-Invasive Monitoring of Potassium Imbalance

Feb. 16, 2021
Aidar Health Receives CE Mark Approval for MouthLab, a Medical Tricorder Optimized for Rapid Health Assessment
press release | StartUp Health podcast with CEO Sathya Elumalai

Jan. 14, 2021
Partner Alio Featured in the GIANT Healthy Innovators Live TV Event (season 3, episode 1)


Dec. 15, 2020
GS Lab and iO life science Partner to Accelerate Patient Centric Medical Device Development

Nov. 10, 2020
Alio Introduces Series of Studies for Clinical-Grade Noninvasive Wearable

Oct. 28, 2020
How an Implantable Dialysis Device May Extend Life for People with Kidney Failure

Oct. 13, 2020
Alessa Therapeutics Announces First Patient Enrolled in Biolen-PC Study for Localized Drug Delivery for Prostate Cancer

Sep. 21, 2020
Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant

Aug. 6, 2020
Oncodisc, Inc. Awarded Competitive Grant from the National Science Foundation to Develop Cancer Technology
